
Himadri Speciality Chemical Approves Capex for New Projects
Himadri Speciality Chemical Ltd announced board approval for significant capital expenditures across multiple projects. The company will invest ₹128 Crores to expand Anthraquinone and Carbazole manufacturing capacity, ₹70 Crores for India's first Carbon Nano Tubes (CNT) facility, and ₹170 Crores for Super Speciality Carbon Black production. These expansions aim to enhance production of high-value specialty products and reduce import dependency, aligning with the 'Atmanirbhar Bharat' vision. The board also approved the unaudited financial results for the quarter ended 30 June 2026.
Key Highlights
- Board approved capex for Anthraquinone and Carbazole expansion.
- New capex for India's first Carbon Nano Tubes (CNT) facility approved.
- Investment in Super Speciality Carbon Black manufacturing capacity.
- Expansions focus on high-value specialty products.
- Unaudited financial results for Q1 FY27 declared.
Price Impact
More from HSCL
Himadri Speciality Chemical Reports Record Q1 FY27 Revenue of ₹1,432 Cr
Himadri Speciality Chemical: No Deviation in Preferential Issue Proceeds Utilization
Himadri Speciality Chemical Approves Capex for Anthraquinone, CNT, SSCB